HCV EU infographic
Research findings from our Therapy HCV study shows that 28% of HCV patients in the EU are infected by sharing needles or drug equipment.
Our latest market snapshot offers an introduction to the real world patient data collected by our Therapy Watch HCV study, providing you with an overview of HCV patient profiles and treatment pathways.
Click here to view our infographic »
Sign up to receive Rapport Rapport is our e-newsletter and online resource for sharing our expertise and experience in global healthcare market research. Sign up here »
Investigating factors affecting time to initiation of hepatitis treatment
Following the Viral Hepatitis Congress 2014 in Germany where Darren Kottler presented a poster presentation, he shares some of the factors affecting time from diagnosis to initiation of therapy in hepatitis patients.
By analysing the factors that lead to a patient to be treated for hepatitis, Therapy Watch data can illustrate the key elements of the patient’s condition that lead to one patient being treated sooner than another.